about
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisCNS Remyelination and the Innate Immune SystemRemyelination Therapy in Multiple SclerosisThe polarity protein Scribble regulates myelination and remyelination in the central nervous systemPPARĪ³ as a therapeutic target to rescue mitochondrial function in neurological diseaseInsights into the physiological role of CNS regeneration inhibitorsImaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple SclerosisQuetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair.The role of MRI in the evaluation of secondary progressive multiple sclerosis.Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortexInhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeuticMechanisms and pharmacology of neuropathic pain in multiple sclerosis.Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.Longitudinal Evaluation of Visual Function in Multiple Sclerosis.A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditionsTai chi for health benefits in patients with multiple sclerosis: A systematic review.Regeneration of myelin sheaths of normal length and thickness in the zebrafish CNS correlates with growth of axons in caliber.Perspectives on neuroreparative therapies for treating multiple sclerosis.Harnessing the integrated stress response for the treatment of multiple sclerosis.FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.Activation of oligodendroglial Stat3 is required for efficient remyelination.Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.Therapeutic antibodies in stroke.Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis.Dynamic imaging of individual remyelination profiles in multiple sclerosis.Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryNeuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiationNeurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosisMindfulness based interventions in multiple sclerosis--a systematic review.Integrin-Linked Kinase (ILK) Deletion Disrupts Oligodendrocyte Development by Altering Cell CycleMultiple sclerosis: experimental models and reality.Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.Signaling mechanisms regulating myelination in the central nervous system.
P2860
Q26740330-597486B8-B046-41BC-BBB8-EE0744832A9AQ26747242-02624D20-2472-4288-B17D-CBC728CB2096Q26772359-F7D07D1C-AB0A-49AE-B486-7614C8ED23F1Q27312603-EF5B8149-B838-48DD-8E18-02CE81864C58Q28069549-642D1BDA-51C7-426D-9055-907D11F36C89Q28084579-DD6D5ABB-AC4E-40D3-AA90-DE89B40B556FQ28267527-BC25C328-6904-44D6-B965-6C01314D9C74Q30656233-86A65663-BABE-4556-A7A5-144DC2094E15Q31033345-B6EBB947-04EA-4577-84A8-1139D2990E7CQ33735496-9BAC7EA1-BEBB-45BC-A22C-BDEFD5E610F9Q34376913-5EFAFD0D-DC89-41A3-A127-D90BBB3A9DAFQ34543420-E554365F-94F4-4C64-B15A-88E2B6DED2A3Q34686977-33D46FA2-A1F9-4F25-B1D5-ED0F1798859FQ35180234-50709FDF-E651-43FF-820D-D6ACCDE78065Q35731415-B1FF2474-02D2-4641-A94B-C0EF4E4D7822Q35902446-16175F1C-5662-40B5-8C4B-210E21D48ED9Q36052912-E4D5E664-0807-419F-A0C6-3DFAE0643C1AQ36090219-F67920F5-E11A-4D18-8D1F-4C6E56D27FE4Q36122722-EC9CB86B-1020-4D06-8D7C-BAF15C661246Q36133389-B8FF84C1-C4A6-4CAF-A220-7F14AF8B9FE2Q36275161-2F5CBC9D-061F-454C-B123-119D23CBE8ECQ36380800-067F0E6B-FEC0-4F65-BB99-A14DB957BF74Q36443617-6E5FCA4D-2E1F-4038-8376-2A56C136413CQ36689566-45C04789-7240-424F-A5CC-48BE257999AEQ37024738-4B61361D-B334-416F-B103-AE7156E1F877Q37080194-D0F594C4-F6DD-4FBD-A021-1ED95BDD73D7Q37129632-D0711DAC-D90E-4E41-A155-44EC1DC2E7E0Q37184238-87E3599B-DE0A-47C8-B583-88EC5E7B550AQ37209235-91581AA2-C307-4542-926E-62BE2F4CF2C4Q37221452-6CE6531E-C706-4B8A-BAF7-BB0A3C7E1060Q37221998-278DFB2A-958C-4DE4-A898-3125D2C563EBQ37289783-94ECCCB5-A54B-4439-B06E-0A52FC6A58D6Q37462045-299FDAB1-F8E2-4E53-BBF8-083A198ED262Q37493548-32B5186D-F4BC-4503-B999-A431522E03C6Q37510816-289C0BD8-5A5D-4613-B832-A7B20C0520B5Q37592138-80C498A0-6DA9-499D-B867-81C8B4796AACQ37596784-52FFF156-D347-47C2-8998-582EFEBF1BFBQ37599583-DD41A493-2A66-4455-822A-F22E12025349Q37739872-3D1ECE45-C87D-4B1B-BF50-89E61FD80C04Q38096247-70BC0646-FCA7-4F80-8339-03168CCA657A
P2860
description
article cientĆfic
@ca
article scientifique
@fr
articol ČtiinČific
@ro
articolo scientifico
@it
artigo cientĆfico
@gl
artigo cientĆfico
@pt
artigo cientĆfico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artĆculo cientĆfico
@es
name
Neuroprotection and repair in multiple sclerosis.
@en
type
label
Neuroprotection and repair in multiple sclerosis.
@en
prefLabel
Neuroprotection and repair in multiple sclerosis.
@en
P2093
P2860
P1476
Neuroprotection and repair in multiple sclerosis.
@en
P2093
Charles ffrench-Constant
Julia M Edgar
Kenneth J Smith
Robin J M Franklin
P2860
P2888
P304
P356
10.1038/NRNEUROL.2012.200
P407
P577
2012-10-02T00:00:00Z
P6179
1000621625